Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (176)	9/25/2009 5:48:25 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 421

I really don't know the answer......but were the interim updates on the full 900+ total patients in the trial? If anyone entered the trial the final date for opening the data would be from the last patient;s complete time in the trial and follow-up period. My wishful thinking is that they want some leeway on reporting....if it's good news and data is opened for review, we could get the release at anytime. Your concern of waiting to the end of year is correct...the longer we go..........they more we should be concerned with data. There has always been my concern that the longer the time that patients are on the drug.....the greater potential for OP to develop. I only hope this is a concern that we should be worried. As I mentioned......I got the feeling that the CEO wanted to talk about the PFE effort and the cancer program, but has to wait for more definite events.